@mesentech.com
Innovative drugs that rebuild bone lost to disease and trauma.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
Mesentech is a cutting-edge brand at the forefront of regenerative medicine. With a focus on rebuilding bone lost due to disease and trauma, Mesentech offers innovative drugs that deliver targeted treatments to the bone. Led by renowned pharmaceutical chemist Dr.
Robert Young, Mesentech has developed a groundbreaking drug conjugate called MES1022. This bone-targeted prodrug shows immense potential in reversing bone loss caused by conditions like Duchenne muscular dystrophy and osteoporosis. But Mesentech doesn't stop there.
The brand is also utilizing bi-specific drug conjugate technology to create new treatments for hematological and gastrointestinal diseases. They collaborate with esteemed partners and investors who share their vision of advancing medicine. Founded by a talented team of experts, including stem cell biologists, cellular and molecular biologists, and nano-particle biochemists, Mesentech is pushing the boundaries of regenerative medicine.
Located in Vancouver, Canada, they are dedicated to improving lives through their groundbreaking research and development. Discover the future of medicine with Mesentech and join their mission to unlock the potential of regenerative therapies. Visit their website to learn more and stay updated with the latest breakthroughs in the field
Company Type
Privately Held
Company Size
11-50
Year Founded
2018
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories